Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann King

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2023
Continuous Glucose Monitoring Enabled by Fluorescent Nanodiamond Boronic HydrogelJian Zhang, Yongjun Zheng, Jimmy Lee, et al.
Archives of Pathology & Laboratory Medicine|January 13, 2026
Phenotype-Driven In Silico Proficiency Testing Represents a Viable Approach for Undiagnosed Disorders by Exome SequencingRyan J Schmidt, Birgit Funke, Ann King, et al.
Nutrients|June 2, 2021
(-)-Oleocanthal Nutraceuticals for Alzheimer's Disease Amyloid Pathology: Novel Oral Formulations, Therapeutic, and Molecular Insights in 5xFAD Transgenic Mice ModelAfsana Tajmim, Areli K Cuevas-Ocampo, Abu Bakar Siddique, et al.
Medical Oncology (Northwood, London, England)|August 20, 2005
Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a multicenter phase II study by the Cancer Therapeutic Research GroupWing M Ho, B Ma, Tony Mok, et al.
Cell Reports. Medicine|January 14, 2025
Enabling tumor-specific drug delivery by targeting the Warburg effect of cancerJian Zhang, Tony Pan, Jimmy Lee, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2007
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacyBrigette Ma, Edwin P Hui, Ann King, et al.
Pharmacological Research|May 22, 2020
Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptorKhaldoun S Abdelwahed, Abu Bakar Siddique, Mohamed M Mohyeldin, et al.
Breast (Edinburgh, Scotland)|February 5, 2026
Pleomorphic and florid lobular carcinoma in situ of the Breast: A systematic review of current evidence and knowledge gapsMassimo Ferrucci, Daniele Passeri, Francesco Milardi, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinomaBrigette B Y Ma, Ann King, Y M Dennis Lo, et al.
British Journal of Cancer|March 21, 2018
Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinomaBrigette Ma, Edwin P Hui, Ann King, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 16, 2023
Continuous Glucose Monitoring Enabled by Fluorescent Nanodiamond Boronic HydrogelJian Zhang, Yongjun Zheng, Jimmy Lee, et al.
Archives of Pathology & Laboratory Medicine|January 13, 2026
Phenotype-Driven In Silico Proficiency Testing Represents a Viable Approach for Undiagnosed Disorders by Exome SequencingRyan J Schmidt, Birgit Funke, Ann King, et al.
Nutrients|June 2, 2021
(-)-Oleocanthal Nutraceuticals for Alzheimer's Disease Amyloid Pathology: Novel Oral Formulations, Therapeutic, and Molecular Insights in 5xFAD Transgenic Mice ModelAfsana Tajmim, Areli K Cuevas-Ocampo, Abu Bakar Siddique, et al.
Medical Oncology (Northwood, London, England)|August 20, 2005
Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a multicenter phase II study by the Cancer Therapeutic Research GroupWing M Ho, B Ma, Tony Mok, et al.
Cell Reports. Medicine|January 14, 2025
Enabling tumor-specific drug delivery by targeting the Warburg effect of cancerJian Zhang, Tony Pan, Jimmy Lee, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2007
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacyBrigette Ma, Edwin P Hui, Ann King, et al.
Pharmacological Research|May 22, 2020
Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptorKhaldoun S Abdelwahed, Abu Bakar Siddique, Mohamed M Mohyeldin, et al.
Breast (Edinburgh, Scotland)|February 5, 2026
Pleomorphic and florid lobular carcinoma in situ of the Breast: A systematic review of current evidence and knowledge gapsMassimo Ferrucci, Daniele Passeri, Francesco Milardi, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinomaBrigette B Y Ma, Ann King, Y M Dennis Lo, et al.
British Journal of Cancer|March 21, 2018
Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinomaBrigette Ma, Edwin P Hui, Ann King, et al.
Pageof 5